Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The preantibiotic era has returned

Archives of Internal Medicine

Volumn 162, Issue 13, 2002, Pages 1515-1520

  Landman, David ^a   Quale, John M ^a   Mayorga, David ^a   Adedeji, Adedeyo ^a   Vangala, Kalyani ^a   Ravishankar, Jayshree ^a   Flores, Carlos ^a   Brooks, Steven ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KINGSBROOK JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; SULTAMICILLIN; TAZOBACTAM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CITY; DNA FINGERPRINTING; EPIDEMIC; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RIBOTYPING; UNITED STATES;

EID: 0037043221     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.13.1515     Document Type: Article

References (27)

1. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
2. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage
3. Prevalence of Acinetobacter spp isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network
4. Antimicrobial activity and spectrum investigation of eight broadspectrum β-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States
5. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide
6. Antibacterial drugs today: II
7. Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria
8. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
9. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) surveillance report, data summary from January 1996 through December 1997: A report from the National Nosocomial infections Surveillance (NNIS) System
10. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods
11. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
12. Worldwide emergence of carbapenem-resistant Acinetobacter spp
13. IMP allelic variants carried by gene cassettes of different phylogeny
14. Characterization of a nosocomial outbreak caused by a Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High level carbapenem resistance in A baumannii is not due solely to the presence of β-lactamases
15. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital
16. Outer-membrane proteins pattern and detection of β-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil
17. Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein
18. Acinetobacter spp as nosocomial pathogens: Microbiological, clinical, and epidemiological features
19. Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital
20. Are we doing enough to contain Acinetobacter infections?
21. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: Results of the case-control and molecular epidemiologic investigations
22. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii
23. Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology
24. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: Correlation with amikacin usage
25. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000
26. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
27. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: Epidemiology and relation to antibiotic usage patterns